Biljana Govedarica

712 total citations
16 papers, 610 citations indexed

About

Biljana Govedarica is a scholar working on Pharmaceutical Science, Organic Chemistry and Materials Chemistry. According to data from OpenAlex, Biljana Govedarica has authored 16 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 6 papers in Organic Chemistry and 4 papers in Materials Chemistry. Recurrent topics in Biljana Govedarica's work include Fullerene Chemistry and Applications (6 papers), Drug Solubulity and Delivery Systems (5 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). Biljana Govedarica is often cited by papers focused on Fullerene Chemistry and Applications (6 papers), Drug Solubulity and Delivery Systems (5 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). Biljana Govedarica collaborates with scholars based in Slovenia, Serbia and Hungary. Biljana Govedarica's co-authors include Stane Srčič, Nataša Radić, Rade Injac, Aleksandar Djordjević, Borut Štrukelj, Rok Dreu, Anton Cerar, Martina Perše, Rok Šibanc and Julijana Kristl and has published in prestigious journals such as Biomaterials, International Journal of Pharmaceutics and Chemical Engineering Science.

In The Last Decade

Biljana Govedarica

16 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Biljana Govedarica Slovenia 11 176 165 161 159 102 16 610
Anahita Fathi Azarbayjani Iran 19 128 0.7× 303 1.8× 193 1.2× 286 1.8× 205 2.0× 45 995
Satyanarayan Pattnaik India 14 101 0.6× 209 1.3× 305 1.9× 176 1.1× 223 2.2× 38 784
Sun Woo Jang South Korea 19 75 0.4× 213 1.3× 217 1.3× 83 0.5× 106 1.0× 40 952
Kalpana Swain India 14 42 0.2× 199 1.2× 276 1.7× 170 1.1× 201 2.0× 27 686
Bao Chen China 10 69 0.4× 154 0.9× 231 1.4× 97 0.6× 185 1.8× 20 606
Dong Xun Li South Korea 14 64 0.4× 119 0.7× 339 2.1× 119 0.7× 270 2.6× 20 849
Lăcrămioara Ochiuz Romania 16 110 0.6× 105 0.6× 242 1.5× 171 1.1× 315 3.1× 78 934
Déborah Michel Canada 17 109 0.6× 77 0.5× 96 0.6× 86 0.5× 75 0.7× 36 695
Tahmer Sharkawi France 16 27 0.2× 64 0.4× 234 1.5× 87 0.5× 124 1.2× 33 534
Maria Tannous Italy 9 47 0.3× 41 0.2× 168 1.0× 82 0.5× 167 1.6× 13 500

Countries citing papers authored by Biljana Govedarica

Since Specialization
Citations

This map shows the geographic impact of Biljana Govedarica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biljana Govedarica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biljana Govedarica more than expected).

Fields of papers citing papers by Biljana Govedarica

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biljana Govedarica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biljana Govedarica. The network helps show where Biljana Govedarica may publish in the future.

Co-authorship network of co-authors of Biljana Govedarica

This figure shows the co-authorship network connecting the top 25 collaborators of Biljana Govedarica. A scholar is included among the top collaborators of Biljana Govedarica based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biljana Govedarica. Biljana Govedarica is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cal, Krzysztof, Magdalena Nowacka, Wiktoria Struck‐Lewicka, et al.. (2015). Roxithromycin-loaded lipid nanoparticles for follicular targeting. International Journal of Pharmaceutics. 495(2). 807–815. 39 indexed citations
2.
Ilić, Ilija German, Biljana Govedarica, Rok Šibanc, Rok Dreu, & Stane Srčič. (2013). Deformation properties of pharmaceutical excipients determined using an in-die and out-die method. International Journal of Pharmaceutics. 446(1-2). 6–15. 74 indexed citations
3.
Šibanc, Rok, et al.. (2012). Physical properties of pharmaceutical pellets. Chemical Engineering Science. 86. 50–60. 18 indexed citations
4.
Pelipenko, Jan, Petra Kocbek, Biljana Govedarica, et al.. (2012). The topography of electrospun nanofibers and its impact on the growth and mobility of keratinocytes. European Journal of Pharmaceutics and Biopharmaceutics. 84(2). 401–411. 73 indexed citations
5.
Govedarica, Biljana, Ilija German Ilić, Rok Šibanc, Rok Dreu, & Stane Srčič. (2012). The use of single particle mechanical properties for predicting the compressibility of pharmaceutical materials. Powder Technology. 225. 43–51. 33 indexed citations
6.
Govedarica, Biljana, Tamás Sovány, Klára Pintye‐Hódi, et al.. (2011). Addressing potent single molecule AFM study in prediction of swelling and dissolution rate in polymer matrix tablets. European Journal of Pharmaceutics and Biopharmaceutics. 80(1). 217–225. 10 indexed citations
7.
Pajk, Stane, et al.. (2011). A novel fluorescent probe for more effective monitoring of nanosized drug delivery systems within the cells. International Journal of Pharmaceutics. 416(1). 384–393. 21 indexed citations
8.
Govedarica, Biljana, Miha Škarabot, Ilija German Ilić, et al.. (2011). Mapping the local elastic properties of pharmaceutical solids using atomic force microscopy. Procedia Engineering. 10. 2857–2866. 1 indexed citations
9.
Govedarica, Biljana, et al.. (2010). Nanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibition. International Journal of Pharmaceutics. 396(1-2). 149–155. 39 indexed citations
10.
Govedarica, Biljana. (2009). Formulation and evaluation of immediate release tablets with different types of paracetamol powders prepared by direct compression. African Journal of Pharmacy and Pharmacology. 5(1). 31–41. 20 indexed citations
11.
Injac, Rade, Nataša Radić, Biljana Govedarica, et al.. (2009). Acute doxorubicin pulmotoxicity in rats with malignant neoplasm is effectively treated with fullerenol C60(OH)24 through inhibition of oxidative stress. Pharmacological Reports. 61(2). 335–342. 69 indexed citations
12.
Injac, Rade, Nataša Radić, Biljana Govedarica, Aleksandar Djordjević, & Borut Štrukelj. (2009). Protective effects of fullerenol against chronic doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Hemijska industrija. 63(3). 259–268. 3 indexed citations
13.
Govedarica, Biljana, Vukosava Milic Torres, Nataša Radić, Branislava Srđenović Čonić, & Aleksandar Djordjević. (2008). Influence of fullerenol C60(OH)24 on enzime status in serum of rats after single dose administration of doxorubicine. Hemijska industrija. 62(3). 191–196. 1 indexed citations
14.
Injac, Rade, Martina Perše, Nataša Radić, et al.. (2008). Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials. 30(6). 1184–1196. 162 indexed citations
15.
Torres, Vukosava Milic, Karmen Stankov, Rade Injac, et al.. (2008). Activity of Antioxidative Enzymes in Erythrocytes after a Single Dose Administration of Doxorubicin in Rats Pretreated with Fullerenol C60(OH)24. Toxicology Mechanisms and Methods. 19(1). 24–28. 38 indexed citations
16.
Jaćević, Vesna, Vukosava Milic Torres, Viktorija Dragojević-Simić, et al.. (2007). Protective effects of fullerenol C60(OH)24 on doxorubicin-induced hepatotoxicity in rats: Pathohistological study. Toxicology Letters. 172. S146–S146. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anahita Fathi Azarbayjani Breakdown of academic impact, for papers by Satyanarayan Pattnaik Breakdown of academic impact, for papers by Sun Woo Jang Breakdown of academic impact, for papers by Kalpana Swain Breakdown of academic impact, for papers by Bao Chen Breakdown of academic impact, for papers by Dong Xun Li Breakdown of academic impact, for papers by Lăcrămioara Ochiuz Breakdown of academic impact, for papers by Déborah Michel Breakdown of academic impact, for papers by Tahmer Sharkawi Breakdown of academic impact, for papers by Maria Tannous
Rankless by CCL
2026